CBD Psychiatric Claims Need Standardized Products and Safety Monitoring
TL;DR: A 2026 paper in Neuropsychopharmacology argued that cannabidiol (CBD), a non-intoxicating cannabis compound, has plausible psychiatric and neurological uses, but clinical claims need standardized products, exposure tracking, and safety monitoring before retail CBD can be treated like medicine. Key Findings Epilepsy evidence is strongest: Approved prescription CBD has the clearest support in rare pediatric …
